The First 100 Days of a Kirsten Gillibrand Presidency: What the Record Suggests

Hero image: New York State Capitol, Albany — via Wikimedia Commons.

01 The scenario

This is a scenario analysis, not a prediction that the person will become president and not an endorsement or criticism of the person. This article does not predict that Kirsten Gillibrand will become president. It asks a hypothetical question: if the New York Democrat were ever sworn in, what would the first 100 days look like based on her documented record?

Gillibrand has run for president before (2020) and her record is unusually legible on two fronts a president controls immediately: military-justice policy at the Pentagon and AI chip export licensing at Commerce. A reasonable inference from these positions is that a Gillibrand presidency would open with executive action on military-justice prosecution policy and chip-export conditions, with her signature statutes — the Military Justice Improvement Act and the GAIN AI Act — sent to Congress for durability.

02 The record: who Kirsten Gillibrand is

Gillibrand has represented New York in the Senate since 2009, first appointed to fill Hillary Clinton's seat and now in her third full term. She is an attorney (UCLA Law, Dartmouth College), a former corporate lawyer, and a former U.S. House member (NY-20, 2007-2009). She is a senior member of the Senate Armed Services Committee — she previously chaired the Emerging Threats and Capabilities Subcommittee in the 118th Congress — and she carries an Agriculture committee lineage from earlier Congresses. She specializes in national security, military-justice, and food-policy issues.

Her full 119th Congress committee roster beyond Armed Services and Agriculture was not verified in this research pass (earlier Intelligence and EPW memberships are asserted from general knowledge and should be verified before citing). Whether the Safe to Report Act passed both chambers and was signed is likewise not fully confirmed here — NDAA final passage is confirmed, signature timing is not.

03 Military justice: the signature issue, two roads

Gillibrand's defining cause is the Military Justice Improvement Act (MJIA) — removing prosecution decisions for serious crimes from the military chain of command. She has reintroduced it repeatedly with bipartisan cosponsors, citing Pentagon survey findings that nearly 6 in 10 survivors report retaliation. She won the Safe to Report Act, empowering survivors of sexual violence to report without retaliation, and key amendments included in the final FY2026 NDAA. On April 28, 2025, she and Sen. Murkowski (R-AK) sent a bipartisan letter pressing Defense Secretary Pete Hegseth on potential undermining of DoD Sexual Assault Prevention and Response.

The lever split is the scenario's first move. Chain-of-command prosecution policy CAN be changed by DoD directive — a president could order Pentagon policy changes without Congress, which is exactly why she presses secretaries directly. But her vehicle is statute, because a directive can be reversed by the next administration. A reasonable inference from these positions is that a President Gillibrand would sign a day-one directive moving prosecution decisions outside the chain of command, then send the MJIA to Congress to make it permanent: executive action first, statute for durability. Her FY26 NDAA wins on blast-exposure brain-health monitoring within SOCOM and HAVANA Act compensation follow-through show the same pattern.

04 Defense policy and New York installations

Gillibrand's Dec. 17, 2025 release on the FY2026 NDAA lists her wins: a 3.8% troop pay raise, $240M+ in New York authorizations ($90M for the 42nd Infantry Division HQ, $20M for Fort Drum planning and design, $5M for University of Rochester short-pulsed lasers to defeat hypersonic missiles, Defense Innovation Unit expansion, Rome Lab 3A-BMN, biotech manufacturing), plus counter-UAS measures, UAP classification-matrix provisions, cyber tabletop-exercise requirements, and blast-exposure brain-health monitoring within SOCOM. Her quoted line: “Protecting our troops and our national security is of the utmost importance.”

She also passed key provisions of her legislation addressing the traumatic brain injury “epidemic” in service members and veterans, announced while chairing the Emerging Threats subcommittee, and with Sen. Schumer (D-NY) secured extension of Buy America provisions for stainless-steel flatware in the annual defense bill, shoring up Sherrill Manufacturing in Oneida County.

Every item here requires Congress — annual defense-bill leverage is her central power, and a first-100-days Gillibrand defense agenda would be written into her first NDAA request rather than into executive orders.

05 AI chips and export controls

On May 15, 2025, Gillibrand with Schumer denounced the reported Trump-administration AI chip arrangement with Saudi Arabia and the UAE, tying it to Medicaid cuts, after Schumer called it a “security risk” on the Senate floor. She supported the GAIN AI Act, requiring entities exporting advanced AI chips to countries of concern to certify U.S. persons have priority in acquiring those chips.

The lever here is squarely executive: Commerce Department licensing conditions and country-of-concern rules are presidential. The GAIN Act would codify the certification requirements, but a president could impose them administratively on day one. A reasonable inference from these positions is that a Gillibrand White House would tighten AI chip export licensing by executive action in the first 100 days, with the GAIN Act as the congressional backstop.

06 Health care: the shutdown and the ACA tax credits

During the record 2025 government shutdown, Gillibrand's office explicitly framed the stakes: “Today, President Trump and congressional Republicans proved that they would rather shut down the government than make Americans' health care more affordable... 20 million Americans are on the brink of seeing their premiums skyrocket... This is a Republican-manufactured health care crisis with potentially life-threatening consequences.” She voted against the Republicans' Nov. 9, 2025 continuing resolution.

The lever is statutory: the ACA premium tax credits expire without congressional extension, and her shutdown votes tied reopening to their renewal. This would require congressional approval rather than unilateral presidential action — a first-100-days Gillibrand healthcare agenda opens with a bill, not an order.

07 Tariffs and made-in-America manufacturing

Gillibrand opposed Trump's new tariffs on household furniture and other wood products, per her 2025 press release on the topic. Her made-in-America record runs deeper than one statement: the Buy America flatware provisions she secured with Schumer in the annual defense bill are the same instinct applied to procurement.

Tariffs are presidential authority — Section 301, 232 and IEEPA levers a president holds alone. She is an opponent of tariff escalation on consumer goods, so a reasonable inference from these positions is that a President Gillibrand would rescind or decline to extend consumer-goods tariffs by executive action early, and push Buy America procurement standards through both executive rulemaking and statute. Her Appropriations-track food-security work (a DoD food-security program expansion she announced) extends the same pattern to military families.

08 What the record cannot tell us

The evidence runs out in specific places. Her full 119th committee roster beyond SASC and Agriculture was not verified item-by-item in this pass. Whether the Safe to Report Act was formally signed into law (versus included in the passed NDAA) is unconfirmed here. There is not enough public evidence to determine a Gillibrand position on immigration enforcement specifics or on energy policy in this research pass — none is inferred. Her 2028 presidential ambitions are unverified; no formal statement was found, and this article makes no claim about them.

What the record does suggest is a presidency that begins where her oversight letters already point — Pentagon prosecution policy, SAPR program protection, AI chip licensing — and then legislates: the MJIA, the GAIN Act, the ACA tax-credit extension, and a New York-heavy first NDAA. Whether the coalition that passed Safe to Report could be widened to pass the MJIA itself is beyond what the public record can tell us.